[1] |
潘辉, 黄琰璎, 王国新, 等. 粪便基因SDC2和BMP3甲基化联合检测在结直肠癌筛查中的价值[J]. 中国医药导报, 2020, 17(11): 15-19.
|
[2] |
Zhou R, Qiu P, Wang H, et al. Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease[J]. Aging (Albany NY), 2021, 13(3): 4634-4646. DOI: 10.18632/aging.202428.
doi: 10.18632/aging.202428
|
[3] |
Moody L, Dvoretskiy S, An R, et al. The efficacy of miR-20a as a diagnostic and prognostic biomarker for colorectal cancer: a systematic review and meta-analysis[J]. Cancers (Basel), 2019, 11(8): 1111. DOI: 10.3390/cancers11081111.
doi: 10.3390/cancers11081111
|
[4] |
邵书先, 沈忠, 张秀峰, 等. 粪便多基因联合检测在结直肠癌早期筛查中的应用[J]. 中华全科医学, 2020, 18(11): 1819-1822. DOI: 10.16766/j.cnki.issn.1674-4152.001627.
doi: 10.16766/j.cnki.issn.1674-4152.001627
|
[5] |
Yau TO, Tang CM, Harriss EK, et al. Faecal microRNAs as a non-invasive tool in the diagnosis of colonic adenomas and colorectal cancer: a meta-analysis[J]. Sci Rep, 2019, 9(1): 9491. DOI: 10.1038/s41598-019-45570-9.
doi: 10.1038/s41598-019-45570-9
pmid: 31263200
|
[6] |
Duran-Sanchon S, Moreno L, Augé JM, et al. Identification and validation of microRNA profiles in fecal samples for detection of colorectal cancer[J]. Gastroenterology, 2020, 158(4): 947-957.e4. DOI: 10.1053/j.gastro.2019.10.005.
doi: S0016-5085(19)41439-X
pmid: 31622624
|
[7] |
朱富强, 唐亚萍, 彭树松, 等. 粪便中miR-31的表达对结直肠癌早期筛查的价值[J]. 中国医师杂志, 2019, 21(8): 1232-1233. DOI: 10.3760/cma.j.issn.1008-1372.2019.08.032.
doi: 10.3760/cma.j.issn.1008-1372.2019.08.032
|
[8] |
Duran-Sanchon S, Moreno L, Gómez-Matas J, et al. Fecal microRNA-based algorithm increases effectiveness of fecal immunochemical test-based screening for colorectal cancer[J]. Clin Gastroenterol Hepatol, 2021, 19(2): 323-330.e1. DOI: 10.1016/j.cgh.2020.02.043.
doi: 10.1016/j.cgh.2020.02.043
|
[9] |
Brînzan C, Aşchie M, Cozaru G, et al. The diagnostic value of miR-92a, -143, and -145 expression levels in patients with colorectal adenocarcinoma from Romania[J]. Medicine (Baltimore), 2020, 99(35): e21895. DOI: 10.1097/MD.0000000000021895.
doi: 10.1097/MD.0000000000021895
|
[10] |
冷晓旭, 房静远. 粪便标志物DNA和RNA筛查结直肠癌特性分析[J]. 中华医学杂志, 2020, 100(42): 3373-3376. DOI: 10.3760/cma.j.cn112137-20200228-00507.
doi: 10.3760/cma.j.cn112137-20200228-00507
|
[11] |
Ardila HJ, Sanabria-Salas MC, Meneses X, et al. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas[J]. Mol Clin Oncol, 2019, 11(2): 201-207. DOI: 10.3892/mco.2019.1876.
doi: 10.3892/mco.2019.1876
pmid: 31316774
|
[12] |
Sahami-Fard MH, Kheirandish S, Sheikhha MH. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance[J]. Cancer Biomark, 2019, 24(3): 291-297. DOI: 10.3233/CBM-182171.
doi: 10.3233/CBM-182171
pmid: 30883340
|
[13] |
张江国, 汪之沫. 粪便多靶点DNA和miR-135b表达联合检测诊断结直肠癌的价值[J]. 山东医药, 2019, 59(19): 60-63. DOI: 10.3969/j.issn.1002-266X.2019.19.016.
doi: 10.3969/j.issn.1002-266X.2019.19.016
|
[14] |
Yang Q, Zheng W, Shen Z, et al. MicroRNA binding site polymorphisms of the long-chain noncoding RNA MALAT1 are associated with risk and prognosis of colorectal cancer in Chinese Han population[J]. Genet Test Mol Biomarkers, 2020, 24(5): 239-248. DOI: 10.1089/gtmb.2020.0013.
doi: 10.1089/gtmb.2020.0013
|
[15] |
张肖丽, 张月晓, 李萍, 等. 结肠癌患者血清miRNA表达意义及与肠道菌群失调关联性[J]. 中国微生态学杂志, 2022, 34(1): 46-51. DOI: 10.13381/j.cnki.cjm.202201008.
doi: 10.13381/j.cnki.cjm.202201008
|
[16] |
Feng Y, Xu Y, Gao Y, et al. A novel lncRNA SOX2OT promotes the malignancy of human colorectal cancer by interacting with miR-194-5p/SOX5 axis[J]. Cell Death Dis, 2021, 12(5): 499. DOI: 10.1038/s41419-021-03756-y.
doi: 10.1038/s41419-021-03756-y
pmid: 33993197
|
[17] |
Wu S, Sun H, Wang Y, et al. MALAT1 rs664589 polymorphism inhibits binding to miR-194-5p, contributing to colorectal cancer risk, growth, and metastasis[J]. Cancer Res, 2019, 79(20): 5432-5441. DOI: 10.1158/0008-5472.CAN-19-0773.
doi: 10.1158/0008-5472.CAN-19-0773
pmid: 31311811
|
[18] |
Li G, Wang Q, Li Z, et al. Serum miR-21 and miR-210 as promising non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer[J]. Rev Esp Enferm Dig, 2020, 112(11): 832-837. DOI: 10.17235/reed.2020.6801/2019.
doi: 10.17235/reed.2020.6801/2019
pmid: 33054296
|
[19] |
连戴政, 刘雅洁. 粪便miRNA标志物在结直肠癌筛选和诊断中的应用研究进展[J]. 肿瘤学杂志, 2019, 25(4): 310-314. DOI: 10.11735/j.issn.1671-170X.2019.04.B005.
doi: 10.11735/j.issn.1671-170X.2019.04.B005
|
[20] |
Peng Q, Shen Y, Zhao P, et al. Biomarker roles identification of miR-106 family for predicting the risk and poor survival of colorectal cancer[J]. BMC Cancer, 2020, 20(1): 506. DOI: 10.1186/s12885-020-06863-9.
doi: 10.1186/s12885-020-06863-9
pmid: 32493303
|
[21] |
Choi HH, Cho YS, Choi JH, et al. Stool-based miR-92a and miR-144* as noninvasive biomarkers for colorectal cancer screening[J]. Oncology, 2019, 97(3): 173-179. DOI: 10.1159/000500639.
doi: 10.1159/000500639
pmid: 31216561
|
[22] |
王胜, 吴英光, 何孟胜. 血清miR-200a、miR-190联合检测在结直肠癌诊断及预后评估中的应用价值[J]. 国际消化病杂志, 2019, 39(4): 286-290. DOI: 10.3969/j.issn.1673-534X.2019.04.011.
doi: 10.3969/j.issn.1673-534X.2019.04.011
|
[23] |
Xu M, Chen X, Lin K, et al. lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer[J]. J Hematol Oncol, 2019, 12(1): 3. DOI: 10.1186/s13045-018-0690-5.
doi: 10.1186/s13045-018-0690-5
|
[24] |
Xu K, Zhan Y, Yuan Z, et al. Hypoxia induces drug resistance in colorectal cancer through the HIF-1α/miR-338-5p/IL-6 feedback loop[J]. Mol Ther, 2019, 27(10): 1810-1824. DOI: 10.1016/j.ymthe.2019.05.017.
doi: S1525-0016(19)30264-3
pmid: 31208913
|